What is Intermittent IV-MP? Treatment for Relapsing Remitting Multiple Sclerosis Patients?
To date, the use of intravenous methylprednisolone has been the standard procedure for treating RR-MS. If it can alleviate the symptoms during episodes seen in multiple sclerosis patients, then it’s only logical to suggest that intermittent doses of intravenous methylprednisolone would decrease the severity of symptoms AND prevent future episodes in remitting relapsing MS. However, ...